Joseph W. LaPlume, EVP, Corporate Strategy & Develop at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sold 18,256 shares at $172.77 ($3.2M) on 2023-11-09, disclosed to the SEC on 2023-11-13.
Open-market sale of $3.2M CRL by EVP, Corporate Strategy & Develop. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $172.77 | 2,585 | $447K | 14.1% |
| 2 | $172.77 | 2,585 | $447K | 14.1% |
| 3 | $173.76 | 6,543 | $1.1M | 35.9% |
| 4 | $173.76 | 6,543 | $1.1M | 35.9% |
| Total | $173.48 avg | 18,256 | $3.2M | 100% |
| Filing → |
| CRL | SELL | 2025-08-20 | $126K | — | Filing → |
| CRL | SELL | 2025-08-08 | $60K | — | Filing → |
| CRL | SELL | 2025-05-15 | $73K | — | Filing → |